American Cancer Society updates prostate cancer screening guideline: Regular PSA testing for average- and high-risk men
The American Cancer Society (ACS) today released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease. Key changes include a direct recommendation for prostate-specific antigen (PSA)-based screening every two years for average-risk men aged 50–69, with clinicians ensuring patients understand the potential benefits, limitations and harms before starting screening. Also, ACS recommends annual…